Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OXBRIDGE RE HOLDINGS LtdOXBR · Entity 7972 | Director | March 28, 2022 | April 01, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OXBRIDGE RE HOLDINGS Ltd
Report date March 28, 2022 · Filed April 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, Par Value $0.001SEC Table I · non-derivative | Direct | 51,000 |
Reported balance
After 2022-03-28 transaction · row 1
1 source rowRow 1 · 2022-03-28 · Grant · Acquired 16,000 · Balance 51,000 F1: This restricted stock grant vests in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st, and January 1st of each calendar year, over a four-year period. |
| Ordinary Shares, Par Value $0.001SEC Table I · non-derivative | IndirectSee Footnote | 118,572 |
Reported balance
Holding disclosure · report date 2022-03-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 118,572 F2: Shares indirectly held in the name of Moksha Capital Partners RE (A) Ltd. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities. |
| Share Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2031-03-02 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2022-03-28 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 50,000 F3: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. |
| Warrants to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2024-03-26 | IndirectSee footnote | 59,286 |
Reported balance
Holding disclosure · report date 2022-03-28 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 59,286 F4: Currently exercisable. F2: Shares indirectly held in the name of Moksha Capital Partners RE (A) Ltd. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities. |
| Warrants to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2024-03-26 | Direct | 105,000 |
Reported balance
Holding disclosure · report date 2022-03-28 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 105,000 F4: Currently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: This restricted stock grant vests in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st, and January 1st of each calendar year, over a four-year period.
F2: Shares indirectly held in the name of Moksha Capital Partners RE (A) Ltd. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.
F3: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period.
F4: Currently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2022 Filed Apr 1, 2022 17:36 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantOrdinary Shares, Par Value $0.001 | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007878 · doc1.xml · nonDerivative · entry 1 Persaud Krishna · CIK 0001439933 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 F1 · shares: This restricted stock grant vests in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st, and January 1st of each calendar year, over a four-year period. Read SEC document |
| March 02, 2021 Filed Apr 13, 2021 12:26 UTC | OXBRIDGE RE HOLDINGS Ltd OXBR · Entity 7972 | GrantShare Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007959 · doc1.xml · derivative · entry 3 Persaud Krishna · CIK 0001439933 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2031-03-02 F2 · kind: This option grant was previously reported on a Form 8-K filed by the issuer on March 8, 2021. F3 · derivative.exercise_date: These share options vest in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.